Hospitalized Patients Clinical Trial
Official title:
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients: a Multicenter Retrospective Study in China
NCT number | NCT05749445 |
Other study ID # | AEATN |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | December 15, 2022 |
Est. completion date | April 2023 |
The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | April 2023 |
Est. primary completion date | April 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - hospitalized patients receiving at least one dose nirmatrelvir-ritonavir Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
China | Changcheng Shi | Hangzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
First People's Hospital of Hangzhou | First People's Hospital of Lin'an District, First People's Hospital of Yuhang District, Hangzhou Cancer Hospital |
China,
Akinosoglou K, Schinas G, Gogos C. Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir. Viruses. 2022 Nov 17;14(11):2540. doi: 10.3390/v14112540. — View Citation
Lamb YN. Nirmatrelvir Plus Ritonavir: First Approval. Drugs. 2022 Apr;82(5):585-591. doi: 10.1007/s40265-022-01692-5. Erratum In: Drugs. 2022 Jun;82(9):1025. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The prevalence of inappropriate use of nirmatrelvir-ritonavir | Four aspects were evaluated to identify the rationality of prescribing NMVr, including indication, administration (dose, timing, and duration), contraindications, and drug-drug interactions. | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04112745 -
The Effect of Magnetic Therapy on Pain Relief in Postoperation Patients
|
N/A | |
Completed |
NCT02959632 -
Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center
|
N/A | |
Completed |
NCT03354468 -
The Effects of a Fall Prevention Program on Falls, Patient Safety Culture and Patient-perceived Safety
|
||
Completed |
NCT03224130 -
Supplement to Hospital to Home Outcomes
|
N/A | |
Completed |
NCT00520715 -
Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards
|
N/A | |
Completed |
NCT06403826 -
SHIFT Hospital in Motion (Pilot Study)
|
||
Completed |
NCT04310332 -
1L- vs. 4L-PEG for Bowel Preparation Among Inpatients.
|
||
Completed |
NCT04787510 -
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
|
||
Not yet recruiting |
NCT04520880 -
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
|
||
Terminated |
NCT02119000 -
Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy
|
Phase 4 | |
Completed |
NCT04401150 -
Lessening Organ Dysfunction With VITamin C - COVID-19
|
Phase 3 | |
Recruiting |
NCT06396676 -
SHIFT-Hospital in Motion (Validation Study)
|